These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19284105)
1. [Photodynamic therapy with visudine in combination with intravitreal kenalog in the treatment of choroidal neovascularization]. Neroev VV; Riabina MV; Chikovani KR; Neroeva NV Vestn Oftalmol; 2009; 125(1):55-7. PubMed ID: 19284105 [TBL] [Abstract][Full Text] [Related]
2. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease. Nóbrega M; Bortolotto C; Farah M Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211 [No Abstract] [Full Text] [Related]
3. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Spaide RF; Sorenson J; Maranan L Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration. Ho TC Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825 [No Abstract] [Full Text] [Related]
5. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment. Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538 [TBL] [Abstract][Full Text] [Related]
6. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Spaide RF; Sorenson J; Maranan L Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization. Hussain N; Das T; Rawal H; Kallukuri SB; Mohan Ram LS; Khanna R Indian J Ophthalmol; 2006 Dec; 54(4):247-50. PubMed ID: 17090876 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study. Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600 [TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study. Chan A; Blumenkranz MS; Wu KH; Wang G; Berker N; Parast LM; Sanislo SR Ophthalmic Surg Lasers Imaging; 2009; 40(6):561-9. PubMed ID: 19928721 [TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):245-54. PubMed ID: 17674020 [TBL] [Abstract][Full Text] [Related]
14. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Chaudhary V; Mao A; Hooper PL; Sheidow TG Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638 [TBL] [Abstract][Full Text] [Related]
15. Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration. Singh CN; Saperstein DA Retina; 2008 Jun; 28(6):789-93. PubMed ID: 18536593 [TBL] [Abstract][Full Text] [Related]
16. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797 [TBL] [Abstract][Full Text] [Related]
17. Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization. Liggett PE; Colina J; Chaudhry NA; Tom D; Haffner G Am J Ophthalmol; 2006 Dec; 142(6):1072-4. PubMed ID: 17157599 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial. Maberley D; Ophthalmology; 2009 Nov; 116(11):2149-57.e1. PubMed ID: 19748675 [TBL] [Abstract][Full Text] [Related]
19. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Chan WM; Lai TY; Lau TT; Lee VY; Liu DT; Lam DS Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization. Degenring RF; Jonas JB Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006 [No Abstract] [Full Text] [Related] [Next] [New Search]